Literature DB >> 29600034

Examining the paradox of high high-density lipoprotein and elevated cardiovascular risk.

Kavisha Singh1, Anand Rohatgi1.   

Abstract

Entities:  

Year:  2018        PMID： 29600034      PMCID： PMC5863140          DOI： 10.21037/jtd.2017.12.97

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   3.005


× No keyword cloud information.
  29 in total

Review 1.  High density lipoproteins (HDLs) and atherosclerosis; the unanswered questions.

Authors:  Philip Barter; John Kastelein; Alistair Nunn; Richard Hobbs
Journal:  Atherosclerosis       Date:  2003-06       Impact factor: 5.162

2.  High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (multi-ethnic study of atherosclerosis).

Authors:  Rachel H Mackey; Philip Greenland; David C Goff; Donald Lloyd-Jones; Christopher T Sibley; Samia Mora
Journal:  J Am Coll Cardiol       Date:  2012-07-11       Impact factor: 24.094

3.  Beyond Coronary Calcification, Family History, and C-Reactive Protein: Cholesterol Efflux Capacity and Cardiovascular Risk Prediction.

Authors:  Purav Mody; Parag H Joshi; Amit Khera; Colby R Ayers; Anand Rohatgi
Journal:  J Am Coll Cardiol       Date:  2016-05-31       Impact factor: 24.094

4.  Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.

Authors:  William E Boden; Jeffrey L Probstfield; Todd Anderson; Bernard R Chaitman; Patrice Desvignes-Nickens; Kent Koprowicz; Ruth McBride; Koon Teo; William Weintraub
Journal:  N Engl J Med       Date:  2011-11-15       Impact factor: 91.245

5.  Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial.

Authors:  Stephen J Nicholls; H Bryan Brewer; John J P Kastelein; Kathryn A Krueger; Ming-Dauh Wang; Mingyuan Shao; Bo Hu; Ellen McErlean; Steven E Nissen
Journal:  JAMA       Date:  2011-11-16       Impact factor: 56.272

6.  Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease.

Authors:  Paolo Zanoni; Sumeet A Khetarpal; Daniel B Larach; William F Hancock-Cerutti; John S Millar; Marina Cuchel; Stephanie DerOhannessian; Anatol Kontush; Praveen Surendran; Danish Saleheen; Stella Trompet; J Wouter Jukema; Anton De Craen; Panos Deloukas; Naveed Sattar; Ian Ford; Chris Packard; Abdullah al Shafi Majumder; Dewan S Alam; Emanuele Di Angelantonio; Goncalo Abecasis; Rajiv Chowdhury; Jeanette Erdmann; Børge G Nordestgaard; Sune F Nielsen; Anne Tybjærg-Hansen; Ruth Frikke Schmidt; Kari Kuulasmaa; Dajiang J Liu; Markus Perola; Stefan Blankenberg; Veikko Salomaa; Satu Männistö; Philippe Amouyel; Dominique Arveiler; Jean Ferrieres; Martina Müller-Nurasyid; Marco Ferrario; Frank Kee; Cristen J Willer; Nilesh Samani; Heribert Schunkert; Adam S Butterworth; Joanna M M Howson; Gina M Peloso; Nathan O Stitziel; John Danesh; Sekar Kathiresan; Daniel J Rader
Journal:  Science       Date:  2016-03-11       Impact factor: 47.728

7.  Effects of torcetrapib in patients at high risk for coronary events.

Authors:  Philip J Barter; Mark Caulfield; Mats Eriksson; Scott M Grundy; John J P Kastelein; Michel Komajda; Jose Lopez-Sendon; Lori Mosca; Jean-Claude Tardif; David D Waters; Charles L Shear; James H Revkin; Kevin A Buhr; Marian R Fisher; Alan R Tall; Bryan Brewer
Journal:  N Engl J Med       Date:  2007-11-05       Impact factor: 91.245

Review 8.  Update on strategies to increase HDL quantity and function.

Authors:  Danielle Duffy; Daniel J Rader
Journal:  Nat Rev Cardiol       Date:  2009-06-02       Impact factor: 32.419

9.  Relation of black race between high density lipoprotein cholesterol content, high density lipoprotein particles and coronary events (from the Dallas Heart Study).

Authors:  Alvin Chandra; Ian J Neeland; Sandeep R Das; Amit Khera; Aslan T Turer; Colby R Ayers; Darren K McGuire; Anand Rohatgi
Journal:  Am J Cardiol       Date:  2015-01-15       Impact factor: 2.778

10.  Coronary heart disease risks associated with high levels of HDL cholesterol.

Authors:  John T Wilkins; Hongyan Ning; Neil J Stone; Michael H Criqui; Lihui Zhao; Philip Greenland; Donald M Lloyd-Jones
Journal:  J Am Heart Assoc       Date:  2014-03-13       Impact factor: 5.501
View more
  7 in total

1.  Association between extremely high high-density lipoprotein-cholesterol and hypertensive retinopathy: results of a cross-sectional study from Kanagawa Investigation of Total Checkup Data from the National Database-6 (KITCHEN-6).

Authors:  Kei Nakajima; Ryoko Higuchi; Kaori Mizusawa; Teiji Nakamura
Journal:  BMJ Open       Date:  2021-05-11       Impact factor: 2.692

2.  Lower or higher HDL-C levels are associated with cardiovascular events in the general population in rural China.

Authors:  Shasha Yu; Xiaofan Guo; Guang Xiao Li; Hongmei Yang; Liqiang Zheng; Yingxian Sun
Journal:  Lipids Health Dis       Date:  2020-06-25       Impact factor: 3.876

3.  Impaired Glucose Metabolism in People with Extremely Elevated High-Density Lipoprotein Cholesterol and Low Alcohol Consumption: Results of the Kanagawa Investigation of Total Checkup Data from the National Database-3 (KITCHEN-3).

Authors:  Kei Nakajima; Ryoko Higuchi
Journal:  J Clin Med       Date:  2019-11-01       Impact factor: 4.241

4.  Skeletal muscle area and density are associated with lipid and lipoprotein cholesterol levels: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Chantal A Vella; Megan C Nelson; Jonathan T Unkart; Iva Miljkovic; Matthew A Allison
Journal:  J Clin Lipidol       Date:  2020-01-13       Impact factor: 4.766

5.  Prevalence of High HDL Cholesterol and Its Associated Factors Among Tunisian Women of Childbearing Age: A Cross-Sectional Study.

Authors:  Fatma Ben Cherifa; Jalila El Ati; Radhouene Doggui; Myriam El Ati-Hellal; Pierre Traissac
Journal:  Int J Environ Res Public Health       Date:  2021-05-20       Impact factor: 3.390

6.  Anti-Inflammatory HDL Function, Incident Cardiovascular Events, and Mortality: A Secondary Analysis of the JUPITER Randomized Clinical Trial.

Authors:  Oluremi N Ajala; Olga V Demler; Yanyan Liu; Zareen Farukhi; Steven J Adelman; Heidi L Collins; Paul M Ridker; Daniel J Rader; Robert J Glynn; Samia Mora
Journal:  J Am Heart Assoc       Date:  2020-08-15       Impact factor: 5.501

Review 7.  HDL Is Not Dead Yet.

Authors:  Shuhui Wang Lorkowski; Jonathan D Smith
Journal:  Biomedicines       Date:  2022-01-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.